Bongolan, Mychill O.
HRN: 21-49-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2022
CO-AMOXICLAV 625MG (TAB)
07/17/2022
07/23/2022
PO
625mg
TID
Puerperial Sepsis; Presumptive Ptb
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes